JP2026020169A5 - - Google Patents

Info

Publication number
JP2026020169A5
JP2026020169A5 JP2025173688A JP2025173688A JP2026020169A5 JP 2026020169 A5 JP2026020169 A5 JP 2026020169A5 JP 2025173688 A JP2025173688 A JP 2025173688A JP 2025173688 A JP2025173688 A JP 2025173688A JP 2026020169 A5 JP2026020169 A5 JP 2026020169A5
Authority
JP
Japan
Prior art keywords
fibrosis
disease
pharmaceutical composition
composition according
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025173688A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026020169A (ja
Filing date
Publication date
Priority claimed from JP2020502709A external-priority patent/JP7383598B2/ja
Application filed filed Critical
Publication of JP2026020169A publication Critical patent/JP2026020169A/ja
Publication of JP2026020169A5 publication Critical patent/JP2026020169A5/ja
Pending legal-status Critical Current

Links

JP2025173688A 2017-07-21 2025-10-15 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤 Pending JP2026020169A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762535611P 2017-07-21 2017-07-21
US62/535,611 2017-07-21
JP2020502709A JP7383598B2 (ja) 2017-07-21 2018-07-23 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
PCT/US2018/043335 WO2019018855A1 (en) 2017-07-21 2018-07-23 ALPHA PROPELLER PROTEIN KINASE INHIBITORS ("COILED-COIL") ASSOCIATED WITH RHO
JP2023101681A JP7778745B2 (ja) 2017-07-21 2023-06-21 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023101681A Division JP7778745B2 (ja) 2017-07-21 2023-06-21 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤

Publications (2)

Publication Number Publication Date
JP2026020169A JP2026020169A (ja) 2026-02-06
JP2026020169A5 true JP2026020169A5 (https=) 2026-03-31

Family

ID=65015613

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020502709A Active JP7383598B2 (ja) 2017-07-21 2018-07-23 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
JP2023101681A Active JP7778745B2 (ja) 2017-07-21 2023-06-21 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
JP2025173688A Pending JP2026020169A (ja) 2017-07-21 2025-10-15 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2020502709A Active JP7383598B2 (ja) 2017-07-21 2018-07-23 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤
JP2023101681A Active JP7778745B2 (ja) 2017-07-21 2023-06-21 Rho関連コイルドコイル含有プロテインキナーゼの阻害剤

Country Status (7)

Country Link
US (1) US11479533B2 (https=)
EP (1) EP3654970A4 (https=)
JP (3) JP7383598B2 (https=)
CN (1) CN111050766A (https=)
CA (1) CA3070115A1 (https=)
EA (1) EA202090306A1 (https=)
WO (1) WO2019018855A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019161162A1 (en) * 2018-02-16 2019-08-22 Constellation Pharmaceuticals, Inc. P300/cbp hat inhibitors
JP7531379B2 (ja) * 2019-12-31 2024-08-09 財團法人工業技術研究院 βアミノ酸誘導体、これを含むキナーゼ阻害剤および医薬組成物ならびにその使用
CN111707830B (zh) * 2020-07-16 2023-08-15 首都医科大学附属北京朝阳医院 Rock激酶活性在辅助诊断肺损害中的应用
CN111707832B (zh) * 2020-07-16 2023-08-15 首都医科大学附属北京朝阳医院 Rock激酶活性在辅助诊断肾损害中的应用
US20240423998A1 (en) * 2021-11-29 2024-12-26 Woolsey Pharmaceuticals, Inc. Methods of treating agitation and other dementia-associated behavioral symptoms
JPWO2024075838A1 (https=) * 2022-10-07 2024-04-11
WO2025017500A1 (en) * 2023-07-17 2025-01-23 Graviton Bioscience Bv Formulations of rock2 inhibitors for cns disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053941A2 (en) 2001-12-20 2003-07-03 Bristol-Myers Squibb Company Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
TW200306819A (en) 2002-01-25 2003-12-01 Vertex Pharma Indazole compounds useful as protein kinase inhibitors
MXPA05003317A (es) 2002-09-25 2005-07-05 Memory Pharm Corp Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
US8211919B2 (en) 2005-09-02 2012-07-03 Astellas Pharma Inc. Amide derivatives as rock inhibitors
JP2011507850A (ja) 2007-12-21 2011-03-10 ザ スクリプス リサーチ インスティチュート Rhoキナーゼインヒビターとしてのアニリドおよびアナログ
CN105102448B (zh) * 2013-02-28 2018-03-06 百时美施贵宝公司 作为rock1和rock2抑制剂的苯基吡唑衍生物
EP3019475A1 (en) 2013-07-08 2016-05-18 Bristol-Myers Squibb Company Aryl amide kinase inhibitors
WO2015070170A1 (en) * 2013-11-08 2015-05-14 The Translational Genomics Research Institute Compounds for cognitive enhancement and methods of use thereof
JP2017523214A (ja) 2014-08-05 2017-08-17 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company ヘテロ環キナーゼ阻害剤
US11926596B2 (en) * 2017-07-21 2024-03-12 Kadmon Corporation, Llc Inhibitors of Rho associated coiled-coil containing protein kinase
EP3675861A4 (en) * 2017-09-01 2021-01-06 Kadmon Corporation, LLC ALPHA SUPERWINDING PROTEIN KINASE INHIBITORS ("COILED-COIL") ASSOCIATED WITH RHO

Similar Documents

Publication Publication Date Title
JP2026020169A5 (https=)
JP2023126245A5 (https=)
EP1539734B1 (fr) Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens
JP2024167182A5 (https=)
JP2005525323A5 (https=)
JP2022529806A5 (https=)
JP2010523623A5 (https=)
JP2014508106A (ja) スフィンゴシン−1−リン酸−1受容体モジュレーターとしてのアルキンおよびアルケン誘導体
JP2003522753A (ja) アルコキシマロン酸ジニトリルの製造方法
JP2006508987A5 (https=)
JP2020522567A5 (https=)
JPH0314832B2 (https=)
JP2022527294A5 (https=)
JP2006519868A5 (https=)
JP2021506813A5 (https=)
JP2022527401A5 (https=)
JP2024536862A5 (https=)
HU196589B (en) Process for producing diphenyl-methane derivatives and pharmaceutics comprising them
JP2022518778A5 (https=)
WO1999033839A1 (en) Cephem derivatives and a method for producing the compounds and an antibacterial composition containing the compounds
JP2023538645A5 (https=)
JP2025513031A5 (https=)
JPH02262583A (ja) 新規セフェム化合物およびその製造法
DE68929310T2 (de) 3-(Substituierte)-1-Carba(dethia)-3-cephemverbindungen und Cephalosporine und ein Verfahren zu ihrer Herstellung
US5275816A (en) Cephalosporin derivatives